Hawkeye Bio Overview
- Founded
- 2018
- Status
- Private
- Employees
- 5
- Latest Deal Type
- Early Stage VC
- Investors
- 2
Hawkeye Bio General Information
Description
Developer of a non-invasive breath test intended for the detection of lung cancer at all stages of disease. The company's patented and clinically validated test identifies changes in gene expression ratios and detects any symptoms of cancer in the human body, enabling the healthcare industry to improve survival rates and lower costs of treatment.
Contact Information
Website
www.hawkeyebio.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Primary Office
- 2820 Townsgate Road
- Suite 204
- Westlake Village, CA 91361-3074
- United States
Hawkeye Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Early Stage VC | 01-Jan-2020 | Completed | Startup | |||
| 1. Grant | 27-Jun-2019 | Completed | Startup |
Hawkeye Bio Executive Team (2)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| André De Fusco | Co-Founder and Chief Executive Officer | ||
| Paul Dempsey Ph.D | Co-Founder and Chief Scientific Officer |
Hawkeye Bio Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialHawkeye Bio Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| NJF Capital | Corporate Venture Capital | Minority | 000 0000 | 000000 0 | |
| JLABS | Accelerator/Incubator | 000 0000 | 000000 0 |